Skip to main content
. 2018 Nov 6;9:1219. doi: 10.3389/fphar.2018.01219

FIGURE 2.

FIGURE 2

Equilibrium solubility of fenofibrate in group “a” and group “b” of LFCS formulations containing alternation lipid excipients. The formulation represent F1a- C70, F1b- K70, F2a- C70: CMCM (7:3)/TO106V (1/1), F2b- K70:I742(7:3)/TO106V(1/1), F3a- C70: CMCM (7:3)/HCO-30 (1/1), F3b- K70:I742(7:3)/HCO-30 (1/1), F4a- CMCM/HCO-30 (1/1) and F4b - I742/HCO-30 (1/1) respectively. Data are expressed as Mean ± SD, (n = 3).